- Home
- CALM vs VKTX Comparison
CALM vs VKTX Comparison
Compare CALM & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALM
- VKTX
- Stock Information
- Founded
- CALM 1957
- VKTX 2012
- Country
- CALM United States
- VKTX United States
- Employees
- CALM N/A
- VKTX N/A
- Industry
- CALM Farming/Seeds/Milling
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- CALM Consumer Staples
- VKTX Health Care
- Exchange
- CALM Nasdaq
- VKTX Nasdaq
- Market Cap
- CALM 4.4B
- VKTX 3.8B
- IPO Year
- CALM 1996
- VKTX 2015
- Fundamental
- Price
- CALM $87.80
- VKTX $38.08
- Analyst Decision
- CALM Hold
- VKTX Strong Buy
- Analyst Count
- CALM 3
- VKTX 14
- Target Price
- CALM $103.33
- VKTX $87.00
- AVG Volume (30 Days)
- CALM 999.5K
- VKTX 4.9M
- Earning Date
- CALM 10-01-2025
- VKTX 10-22-2025
- Dividend Yield
- CALM 9.52%
- VKTX N/A
- EPS Growth
- CALM 198.25
- VKTX N/A
- EPS
- CALM 26.04
- VKTX N/A
- Revenue
- CALM $4,398,616,000.00
- VKTX N/A
- Revenue This Year
- CALM N/A
- VKTX N/A
- Revenue Next Year
- CALM N/A
- VKTX N/A
- P/E Ratio
- CALM $3.37
- VKTX N/A
- Revenue Growth
- CALM 65.80
- VKTX N/A
- 52 Week Low
- CALM $79.55
- VKTX $18.92
- 52 Week High
- CALM $126.40
- VKTX $79.10
- Technical
- Relative Strength Index (RSI)
- CALM 34.25
- VKTX 66.57
- Support Level
- CALM $85.25
- VKTX $33.00
- Resistance Level
- CALM $88.20
- VKTX $39.57
- Average True Range (ATR)
- CALM 2.35
- VKTX 2.09
- MACD
- CALM 0.05
- VKTX 0.31
- Stochastic Oscillator
- CALM 24.71
- VKTX 82.90
About CALM Cal-Maine Foods Inc.
Cal-Maine Foods Inc produces and sells shell eggs. Its main market is the United States. The company's product portfolio contains nutritionally enhanced, cage-free, organic, and brown eggs. Cal-Maine Foods markets the shell eggs to a diverse group of customers, including grocery-store chains, club stores, and food service distributors. The company's brands are Egg-Land's, Land O' Lakes, Farmhouse, and 4-Grain. The Company has one reportable operating segment, which is the production, grading, packaging, marketing and distribution of shell eggs.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.